FDA Adverse Event Injury Summary report: N

INGEVITY+

MDR report key: 17017832 · Received May 30, 2023

Report

Report Number
2124215-2023-27078
Event Type
Injury
Date Received
May 30, 2023
Date of Event
May 9, 2023
Report Date
June 19, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NVN
UDI-DI
00802526604522
PMA / PMN Number
P150012/S083
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 0

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS SYSTEM WITH A RIGHT VENTRICULAR (RV) LEAD AND AN OFF LABEL IMPLANTED LEFT BUNDLE BRANCH (LBB) LEAD SHOWED NON PHYSIOLOGIC NOISE OVER SENSING. VARIOUS ORIGINS WERE DISCUSSED FOR THIS ISSUE BUT ACCORDING TO THE FIELD REPRESENTATIVE IT WAS DETERMINED THAT THE LBB LEAD WAS TAPPING ON THE RV COIL. IT WAS RECOMMENDED TO REPOSITION THE LBB LEAD. BOTH LEADS REMAIN IN SERVICE AT THIS TIME. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THIS SYSTEM WITH A RIGHT VENTRICULAR (RV) LEAD AND AN OFF LABEL IMPLANTED LEFT BUNDLE BRANCH (LBB) LEAD SHOWED NON PHYSIOLOGIC NOISE OVER SENSING. VARIOUS ORIGINS WERE DISCUSSED FOR THIS ISSUE BUT ACCORDING TO THE FIELD REPRESENTATIVE IT WAS DETERMINED THAT THE LBB LEAD WAS TAPPING ON THE RV COIL. IT WAS RECOMMENDED TO REPOSITION THE LBB LEAD. BOTH LEADS REMAIN IN SERVICE AT THIS TIME. NO ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION WAS RECEIVED FROM THE FIELD REPRESENTATIVE MENTIONING THAT THE SLACK IN THE LBB LEAD WAS PULLED BACK, ELIMINATING CONTACT WITH RV COIL AT THE SAME INITIAL PROCEDURE, BEFORE POCKET CLOSURE. THE LBB LEAD TAPPING THE RV COIL WAS OBSERVED VIA X RAY IN MULTIPLE VIEWS. THE PATIENT WAS FULLY RECOVERED FROM THE PROCEDURE AND THE LEADS REMAIN IN SERVICE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1553047 INGEVITY+ IMPLANTABLE LEAD NVN BOSTON SCIENTIFIC CORPORATION 7842 1191698 00802526604522

Patients

Seq Age Sex Outcome Treatment
1 65 YR Male Required Intervention| H